Ocata Therapeutics, Inc.
Ocata Therapeutics, Inc. (OCAT) is a publicly traded company in the Unknown sector. Across all available filings, 11 corporate insiders have executed 57 transactions totaling $290.9K, demonstrating a bearish sentiment with -$290.9K in net insider flow. The most recent transaction on Feb 10, 2016 involved a transaction of 277,500 shares valued at $2.4M.
OCAT Insider Activity Summary
Who Is Buying OCAT Stock?
No significant insider buying has been recorded for OCAT in the recent period.
Who Is Selling OCAT Stock?
No significant insider selling has been recorded for OCAT in the recent period.
Is Ocata Therapeutics, Inc. Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for OCAT is bearish with an Insider Alignment Score of 0/100 and a net flow of -$290.9K. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
OCAT Frequently Asked Questions
Understanding OCAT Insider Activity
Insider trading at Ocata Therapeutics, Inc. (OCAT) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 11 insiders are actively trading OCAT stock, having executed 57 transactions in the past 90 days. The most active insider is Paul K. Wotton (Executive), who has made 3 transactions totaling $2.5M.
Related Tools
Track Ocata Therapeutics, Inc. Insider Activity
Get notified when executives and directors at OCAT file new Form 4 transactions